5 Best Diabetes Stocks To Buy Now

Page 1 of 5

In this article, we discuss the 5 best diabetes stocks to buy now. If you want to read our detailed analysis of these stocks, go directly to the 10 Best Diabetes Stocks To Buy Now.

5. Abbott Laboratories (NYSE:ABT)

Number of Hedge Fund Holders: 61

Abbott Laboratories (NYSE:ABT) is a $225 billion medical device company that sells diabetes care products including blood glucose monitoring systems and diabetes management systems. In its third-quarter earnings, the Illinois-based healthcare company recorded a 33% year-over-year growth in diabetes care revenue totaling $1.12 billion. Overall, the company’s revenue in the third quarter was $10.93 billion, beating revenue estimates by $1.36 billion.

Aside from the fact that Abbott Laboratories (NYSE:ABT) has a 5-year average sales growth rate of 12.40%, investors value the company’s dividend-paying consistency. The medical device company offers a 1.42% dividend yield.

Following solid third-quarter results, Morgan Stanley analyst David Lewis maintained an Overweight rating on Abbott Laboratories (NYSE:ABT) on October 21 and increased his price target for the stock to $146 from $136.

Page 1 of 5